Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adultsM.L. Piel-Julian, L. Prudhomme, Matthieu Mahévas et al.|Journal of Thrombosis and Haemostasis|2018Cited by 138
Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer CenterGhassan Al Darazi, Thomas Filleron, Muriel Poublanc et al.|International Journal of Cancer|2020Cited by 17
Improving patient selection for immuno-oncology phase I trials: An external validation of five prognostic scores at Claudius Regaud Institute of Toulouse, Oncopôle (IUCT-O)Ghassan Al Darazi, Carlos Gomez‐Roca, E. Martin et al.|Annals of Oncology|2019Cited by 1